No, blood in stool is not listed as a recognised adverse reaction in the MHRA Summary of Product Characteristics for Ozempic, nor does it appear in clinical trial safety data
By purchasing this product, you confirm that you are a qualified researcher and that this product will be used exclusively for legitimate scientific research purposes
Van Schoor J, Joos GF, Chasson BL, Brouard RJ, Pauwels RA
However, adjustments may be considered if: Glycaemic targets are not achieved : Your doctor may increase to the next available dose strength Intolerable side effects persist : A temporary dose reduction or slower titration may be appropriate Weight loss plateaus (for weight management indications): Dose optimisation may be discussed Renal function changes : Monitoring may be increased, though most GLP-1s don't require dose adjustment Other medications are added or removed : Particularly other glucose-lowering agents Important considerations during dose changes: Never skip doses or double up if you miss an injectionfollow the specific guidance in your patient information leaflet For missed doses, each product has different instructions: Semaglutide (Ozempic/Wegovy): If within 5 days, take as soon as possible
PMCID: PMC7554202
People with a hypersensitivity to PT-141 or related drugs: If you have a known allergy or hypersensitivity to PT-141 Max or similar drugs, it is crucial to avoid using it